FTC Would Get Green Light To Go After Patent Thickets Under Bipartisan Senate Bill

Legislation by Sens. Cornyn, R-TX, and Blumenthal, D-CT, in part reflects frustration over AbbVie’s tactics to preserve patent protection for Humira.